A straightforward meta-analysis approach for oncology phase I dose-finding studies
From MaRDI portal
Publication:6628513
DOI10.1002/sim.9484zbMATH Open1547.62435MaRDI QIDQ6628513
Sarah Zohar, Christian Roever, Moreno Ursino, Tim Friede
Publication date: 29 October 2024
Published in: Statistics in Medicine (Search for Journal in Brave)
Cites Work
- Unnamed Item
- Unnamed Item
- Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer
- Operating characteristics of the standard phase I clinical trial design.
- Random-effects meta-analysis of phase I dose-finding studies using stochastic process priors
- Optimal Designs for Dose-Finding Studies
- Statistical Analysis of Financial Data in S-Plus
- On the existence of maximum likelihood estimates in logistic regression models
- Density of the Ratio of Two Normal Random Variables and Applications
- Statistical Methods for Dose‐Finding Experiments
- Robust meta‐analytic‐predictive priors in clinical trials with historical control information
- Statistical Meta‐Analysis with Applications
- Bias reduction of maximum likelihood estimates
- Dose-Finding Designs for Early-Phase Cancer Clinical Trials
- Meta‐analysis of two studies in the presence of heterogeneity with applications in rare diseases
- Statistical properties of the traditional algorithm-based designs for phase I cancer clinical trials
- Combining Multiple Comparisons and Modeling Techniques in Dose‐Response Studies
- Jeffreys-prior penalty, finiteness and shrinkage in binomial-response generalized linear models
- Bounds for the weight of external data in shrinkage estimation
Related Items (1)
This page was built for publication: A straightforward meta-analysis approach for oncology phase I dose-finding studies
